Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey
This section is a general overview and is not a complete list of risks, contraindications, or interactions
author, title, publication year, trial name, trial registry), (2) patient demographics (e.g
Promotional superlatives and headline marketing phrases appearing on the brand's website - including, without limitation, "Clinician Prescribed," "USA Made," "Work with your biology, not against it," "Food Noise," "Muscle Guard," "Doctor-led plans," and "Stop Fighting Your Biology" - are explicitly identified in this article as brand-asserted marketing language and are not represented as independent third-party rankings, performance guarantees, or laboratory-verified claims by this publication